Boston Scientific Corp. closed $1.60 below its 52-week high ($84.12), which the company achieved on September 13th.

((SL Advertiser)) Boston Scientific has prostate cancer solutions at Valley Urologic Associates. To learn more, go to ...

Silk Road Medical said in a securities filing that the antitrust waiting period expired Thursday evening, opening the door to ...

Boston Scientific Corp. closed $0.61 short of its 52-week high ($84.12), which the company reached on September 13th.

Silk Road Medical (NASDAQ:SILK) edged higher by 0.7% in premarket trading after the HSR waiting period for its planned sale ...

Boston Scientific (NYSE: BSX) announced today that it completed its $1.16 billion acquisition of Silk Road Medical ...

Boston Scientific (NYSE: BSX) received FDA approval to expand the indication for its current-generation Ingevity+ pacing ...

Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of California medical ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on TG Therapeutics (TGTX – Research Report) and Boston Scientific (BSX – Research Report) with bullish ...

Investors have rewarded BSX stock thanks to the uptick in its sales for its new products and the Watchman line.

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Boston Scientific (BSX – Research Report), ...

Boston Scientific Corporation announced the close of its acquisition of Silk Road Medical, Inc. the developer of transcarotid ...